Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | DAO | P14920 | 8/20 | 0.44 |
| ▸ | ERCC1 | P07992 | 3/20 | 0.44 |
| ▸ | ERCC4 | Q92889 | 3/20 | 0.44 |
| ▸ | BCL2 | P10415 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | CASP6 | P55212 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31160182 | 0.65 | PARP1 (0.59) | GAADAOERCC1ERCC4KDM4E | |
| SCHEMBL1264071 | 0.65 | PARP1 (0.59) | GAADAOERCC1ERCC4KDM4E | |
| SCHEMBL48366 | 0.65 | — | — | |
| SCHEMBL16654461 | 0.64 | DAO (0.42) | GAADAOERCC1ERCC4KDM4E | |
| SCHEMBL2116156 | 0.63 | — | — | |
| SCHEMBL5175749 | 0.63 | — | — | |
| SCHEMBL13674924 | 0.62 | PARP1 (0.46) | GAADAOERCC1ERCC4ADRA1A | |
| SCHEMBL13760002 | 0.62 | — | — | |
| SCHEMBL10895825 | 0.62 | — | — | |
| SCHEMBL12420716 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118785925-A | Marker precursors and radiotracers with three or more targeting vectors for use in diagnostic nuclear medicine therapies | 原子治疗有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-117642190-A | Dimer-labeled precursor conjugated with a three-linker and radiotracer derived therefrom | 梅迪阿内泽有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116916972-A | Marker precursors and radiotracers for use in nuclear medicine diagnosis and treatment of prostate cancer-induced bone metastases | SCV-特种化学品销售有限公司 | 2023-10-20 | — | — | CN | claimed |
| EP-4168173-A1 | MICROWAVE DEVICE FOR THE RAPID LABELLING OF IN KIT-FORMULATED RADIOPHARMACEUTICALS | C.M.S. S.p.A. (IT) | 2023-04-26 | — | — | EP | claimed |
| CN-114980931-A | Intelligent drug delivery system and kit for nuclear medicine cytotoxicity dual therapy diagnosis | SCV-特种化学品销售有限公司 | 2022-08-30 | — | — | CN | claimed |
| WO-2021234741-A1 | MICROWAVE DEVICE FOR THE RAPID LABELLING OF IN KIT-FORMULATED RADIOPHARMACEUTICALS | C.M.S. S.P.A. (IT) | 2021-11-25 | — | — | WO | claimed |
| EP-3452436-B1 | IN-KIT PREPARATION OF GALLIUM-68 LABELLED RADIOPHARMACEUTICALS | GAMMA SERVIZI S R L (IT) | 2021-10-13 | — | — | EP | claimed |
| CN-113164630-A | Mark precursors with squaric acid linkage | SCV-特种化学品销售有限公司 | 2021-07-23 | — | — | CN | claimed |
| EP-3452436-A2 | IN-KIT PREPARATION OF GALLIUM-68 LABELLED RADIOPHARMACEUTICALS | Azienda USL di Reggio Nell' Emilia (IT) | 2019-03-13 | — | — | EP | claimed |
| CN-118785925-A | Marker precursors and radiotracers with three or more targeting vectors for use in diagnostic nuclear medicine therapies | 原子治疗有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-117642190-A | Dimer-labeled precursor conjugated with a three-linker and radiotracer derived therefrom | 梅迪阿内泽有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-114796533-B | Marking precursors with squaric acid linkages | SCV-特种化学品销售有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-116916972-A | Marker precursors and radiotracers for use in nuclear medicine diagnosis and treatment of prostate cancer-induced bone metastases | SCV-特种化学品销售有限公司 | 2023-10-20 | — | — | CN | disclosed |
| EP-4168173-A1 | MICROWAVE DEVICE FOR THE RAPID LABELLING OF IN KIT-FORMULATED RADIOPHARMACEUTICALS | C.M.S. S.p.A. (IT) | 2023-04-26 | — | — | EP | disclosed |
| EP-2637705-B1 | CONJUGATES AND THEIR USES IN MOLECULAR IMAGING | KING S COLLEGE LONDON (GB) | 2017-03-29 | — | — | EP | disclosed |
| US-20160358683-A1 | PROCESS FOR PRODUCING GALLIUM-68 THROUGH THE IRRADIATION OF A SOLUTION TARGET | ION BEAM APPLICATIONS | 2016-12-08 | — | — | US | disclosed |
| EP-3101660-A1 | PROCESS FOR PRODUCING GALLIUM-68 THROUGH THE IRRADIATION OF A SOLUTION TARGET | Universidade de Coimbra (PT) | 2016-12-07 | — | — | EP | disclosed |
| US-20130157375-A1 | COMPOUND | LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE (GB) | 2013-06-20 | — | — | US | disclosed |
| EP-2564205-A1 | COMPOUND | King's College London (GB) | 2013-03-06 | — | — | EP | disclosed |
| WO-2011135361-A1 | COMPOUND | KING'S COLLEGE LONDON (GB) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130157375-A1 | COMPOUND | TFRC, FTH1, SLC40A1 | GAA 2487/4885DAO 2561/4885ERCC1 2954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.